numbers

[Mirror] Quadratic Arithmetic Programs: from Zero to Hero

Vitalik Buterin via the Vitalik Buterin Blog This is a mirror of the post at https://medium.com/@VitalikButerin/quadratic-arithmetic-programs-from-zero-to-hero-f6d558cea649 There has been a lot of interest lately in the technology behind zk-SNARKs, and people are increasingly trying to demystify something that many have come to call "moon math" due to its perceived sheer indecipherable complexity. zk-SNARKs are indeed quite challenging to grasp, especially due to the sheer number of moving parts that need to come together for the whole thing to work, but if we break the technology down piece by piece then

Unveiling the Inaugural Global Protocol Report: A Comprehensive Analysis of Blockchain Protocols that is Poised to Aid WEB3 Decisions

Crypto Oasis, Crypto Valley, the DLT Science Foundation and Inacta Ventures Join Forces in a Groundbreaking Initiative that Will Help Navigate the Blockchain Trilemma Highlights: The report has unprecedented transparency and clarity, granular insights, and an evolving analysis of DLT protocol attributes. It will help industry experts and novices gain foundational knowledge on DLT concepts, WEB3 ecosystem infrastructure, the evolution of the Blockchain landscape, and the role of capital, talent, infrastructure, and regulations in WEB3 innovation. The Global Protocol Report introduces a comprehensive framework for assessing the maturity of DLT

BitMask Wallet 0.7.0 Soars: A Quantum Leap in Bitcoin Evolution Surges Over 760,000 Wallets in Just One Month

SAN FRANCISCO, November 23, 2023 (ACN Newswire) - DIBA Global, backed by industry titans including Draper Associates, ACTAI Ventures, Waterdrip Capital, Martial Eagle Fund, Brad Mills, Rodney Yesep, and others, has sent shockwaves through the Bitcoin industry with the beta release of BitMask Wallet 0.7.0. This marks a historic moment as the user base surpasses 763,623 wallets. This milestone, achieved without any advertising, underscores the community's trust in DIBA's commitment to advancing Bitcoin utility. Worthy of note is the official partnership between DIBA GLOBAL and Satoshi Lab to foster the development

HealthCare AI: The Unavoidable Revolution in Modern Medicine

By Eric Greenberg www.linkedin.com/in/ericabg In the evolving landscape of medical technology, there's one force that stands head and shoulders above the rest, promising a seismic shift in the very ethos of healthcare delivery: Artificial Intelligence (AI). As a seasoned technology and banking analyst, it is my considered opinion that Healthcare AI isn't just a trend or a buzzword. It’s the very future of medicine, poised to reshape everything we know about patient care, disease diagnosis, and medical research. To begin with, the economic implications of integrating AI in healthcare are

My Health Manifesto : Cracking The Code : Flying Solo

Today when I Google "how long can a person live with my GFR 5% / kidney function the answer was "a few hours to a few weeks without dialysis." In a study with 8000+ patients 65+ with similar numbers; a month was the survival time. @68 (Stage 5 kidney failure is less than 15% /GFR; I'm not even anywhere on/near the chart) As I enter my Fourteenth/14th month; I am Defiantly hopeful. positive and optimistic that My Miracle will continue. #notmytimetodie #superoutlier While I challenge this death sentence I feel better and clearer

Welcome Renal Warriors

I am a 68 year old man born in Brooklyn, New York and living for decades in Ithaca, NY. I also have 10 years each with homes in @San Ramon, Costa Rica and @Austin, Texas. My present and future dreams are in #Africa and I am setting up a base in @CapeTown, South Africa. #notmytimetodie #supportmymiracle #childofimmigrants #latebloomer. I was told a year ago that I would certainly die if I did not have not follow the standard treatment of care. I rejected both dialysis and a transplant and am

Coya Therapeutics Reports Additional Biomarker and Imaging Data Showing Decrease in Neuroinflammation with COYA 301 in Alzheimer’s Disease.

Highlights Coya reports new data illustrating that administration of COYA 301 (low dose Interleukin-2 (IL-2)) in an open- label study in 8 patients with mild to moderate AD (COYA 301 Trial) resulted in a statistically significant reduction in the expression of three well characterized proinflammatory cytokines -- Tumor Necrosis Factor alpha (TNF-α), Interleukin 6 (IL-6), and Interleukin 1- Beta (IL-1β) -- which correlated with lack of cognitive decline of the patients over the course of the study. TNF-α is one of the main inflammatory cytokines involved in initiating and propagating